This can not be good Fresenius has stopped rolling out Omontys
1 in 1000.. in America and Diabetes I am sure that 1 is an unhealthy person who cannot even handle walking up a flight of stairs.. still I am sure Fresenius is overly cautious after the other fatalities they had.. that 1 in 1000 could be a nice haircut?
That is good news but #1 Fresenius is ultra cautious with present fatalities and #2 I DO NOT TRUST AMGEN.. I hope all goes well with Omontys and AFFY but at $16.91 I will sit it out and wait.. it needs a capitulation and this is not it.. especially if the news is true that Fresenius stopped the rollout?
bid $12.95 - ask $13.10... that is what I am talking about.. I have been there too many times.. you can beat off to Affymax all day long and enjoy it if you like? I prefered cutting my loss and 'saving MY MONEY'..